1. Home
  2. BCHT vs TELA Comparison

BCHT vs TELA Comparison

Compare BCHT & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Birchtech Corp. Common Stock

BCHT

Birchtech Corp. Common Stock

SELL

Current Price

$1.29

Market Cap

36.6M

Sector

Industrials

ML Signal

SELL

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

HOLD

Current Price

$0.97

Market Cap

31.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCHT
TELA
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.6M
31.4M
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
BCHT
TELA
Price
$1.29
$0.97
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $1.90
AVG Volume (30 Days)
119.4K
★ 126.0K
Earning Date
11-25-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 37.59
EPS
★ N/A
N/A
Revenue
$17,626,366.00
★ $80,275,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$73.49
$8.58
P/E Ratio
★ N/A
N/A
Revenue Growth
1.26
★ 15.84
52 Week Low
$1.10
$0.50
52 Week High
$2.59
$1.50

Technical Indicators

Market Signals
Indicator
BCHT
TELA
Relative Strength Index (RSI) 41.03 43.17
Support Level $1.14 $0.93
Resistance Level $1.54 $0.97
Average True Range (ATR) 0.09 0.11
MACD -0.01 -0.02
Stochastic Oscillator 33.50 13.80

Price Performance

Historical Comparison
BCHT
TELA

About BCHT Birchtech Corp. Common Stock

Birchtech Corp is a provider of specialty activated carbon technologies, delivering solutions for air and water purification. It provides patented and proprietary Sorbent Enhancement Additive (SEA) technologies for mercury emissions capture to the coal-fired utility sector, and is developing water purification technologies with a specialization on forever chemicals such as PFAS and PFOS. Geographically, the company derives all of its revenue from the United States.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: